Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - mesalazinum - rektal-schaum - mesalazinum 2 g, antiox.: e 224, conserv.: e 211, excipiens aussetzung und propellentia für dosi. - colitis ulcerosa - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - mesalazinum - rektal-schaum - mesalazinum 4 g antiox.: e 224, conserv.: e 211, excipiens aussetzung und propellentia für dosi. - colitis ulcerosa - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - irbesartanum, hydrochlorothiazidum - filmtabletten - irbesartanum 150 mg, hydrochlorothiazidum 12.5 mg, lactosum monohydricum 38.5 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. hypromellosum, silica colloidalis anhydrica, magnesii stearas, pellicule: lactosum monohydricum 3.6 mg, hypromellosum, e 171, macrogolum 3000, e 172 (flavum), e 172 (rubrum), cera carnauba, pro compresso obducto corresp. natrium 1.09281 mg. - hypertonie essentiell - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - irbesartanum, hydrochlorothiazidum - filmtabletten - irbesartanum 300 mg, hydrochlorothiazidum 12.5 mg, lactosum monohydricum 89.5 mg, cellulosum microcristallinum, carmellosum natricum conexum, hypromellosum, silica colloidalis anhydrica, magnesii stearas, pellicule: lactosum monohydricum 7.2 mg, hypromellosum, e 171, macrogolum 3000, e 172 (flavum), e 172 (rubrum), cera carnauba, pro compresso obducto corresp. natrium 2.18562 mg. - hypertonie essentiell - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - irbesartanum, hydrochlorothiazidum - filmtabletten - irbesartanum 300 mg, hydrochlorothiazidum 25 mg, lactosum monohydricum 53.3 mg, cellulosum microcristallinum, carmellosum natricum conexum, amylum pregelificatum, e 172 (rubrum), e 172 (flavum), magnesii stearas, silica colloidalis anhydrica, pellicule: lactosum monohydricum 7.56 mg, hypromellosum, e 171, macrogolum 3350, e 172 (rubrum), e 172 (nigrum), cera carnauba, pro compresso obducto corresp. natrium 2.7345 mg. - hypertonie essentiell - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - insulinum glarginum - solution injectable en cartouche - insulinum glarginum 3.6378 mg corresp. insulinum glarginum 100 u., zinci chloridum, glycerolum (85 per centum), acidum hydrochloridum concentratum, natrii hydroxidum 0.1 mg, metacresolum, aqua ad iniectabile ad solutionem pro 1 ml. - diabetes mellitus - biotechnologika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - insulinum glarginum - injizierbare lösung - insulinum glarginum 3.6378 mg corresp. insulinum glarginum 100 u., zinci chloridum, glycerolum (85 per centum), acidum hydrochloridum concentratum, natrii hydroxidum 0.1 mg, metacresolum, aqua ad iniectabile ad solutionem pro 1 ml. - diabetes mellitus - biotechnologika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - oxybutynini hydrochloridum - tabletten - oxybutynini hydrochloridum 5 mg, color.: e 132, excipiens pro compresso. - spasmolytische der harnwege - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - alirocumabum - lösung zur injektion in fertigspritze - solution: alirocumabum 75 mg, histidini hydrochloridum monohydricum, histidinum, saccharum, polysorbatum 20, aqua ad iniectabile ad solutionem pro 1 ml. - lipidsenker - biotechnologika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - alirocumabum - lösung zur injektion in fertigspritze - solution: alirocumabum 150 mg, histidini hydrochloridum monohydricum, histidinum, saccharum, polysorbatum 20, aqua ad iniectabile ad solutionem pro 1 ml. - lipidsenker - biotechnologika